{"id":1268,"date":"2025-02-25T00:00:00","date_gmt":"2025-02-25T00:00:00","guid":{"rendered":"https:\/\/www.efhss.com\/pharmacy\/la-fda-otorga-el-estatus-de-via-rapida-al-pyx-201-de-pyxis\/"},"modified":"2025-02-27T16:29:32","modified_gmt":"2025-02-27T16:29:32","slug":"la-fda-otorga-el-estatus-de-via-rapida-al-pyx-201-de-pyxis","status":"publish","type":"post","link":"https:\/\/www.efhss.com\/pharmacy\/es\/la-fda-otorga-el-estatus-de-via-rapida-al-pyx-201-de-pyxis\/","title":{"rendered":"La FDA otorga el estatus de v\u00eda r\u00e1pida al PYX-201 de Pyxis."},"content":{"rendered":"<p>Actualmente, hay dos ensayos cl\u00ednicos que reclutan participantes para un tratamiento llamado ADC. La Administraci\u00f3n de Alimentos y Medicamentos de EE. UU. (FDA) ha otorgado la designaci\u00f3n de v\u00eda r\u00e1pida al conjugado anticuerpo-f\u00e1rmaco (ADC) de Pyxis Oncology, PYX-201, para tratar a adultos con carcinoma de c\u00e9lulas escamosas de cabeza y cuello recurrente o metast\u00e1sico (R\/M HNSCC).<\/p>\n<p>Este tratamiento est\u00e1 destinado a personas cuya enfermedad ha progresado despu\u00e9s de recibir quimioterapia basada en platino y un anticuerpo anti-ligando de muerte celular programada (PD-L). PYX-201 se dirige a un componente estructural del tumor llamado Extradomain-B Fibronectina (EDB+FN).<\/p>\n<p>Hay dos ensayos cl\u00ednicos en curso. El primero, PYX-201-101, eval\u00faa el ADC como agente \u00fanico en personas con esta condici\u00f3n. El segundo, PYX-201-102, investiga el ADC junto con Keytruda (pembrolizumab) de MSD, en personas con R\/M HNSCC y otros tumores s\u00f3lidos avanzados. Este ensayo es parte de un acuerdo de colaboraci\u00f3n con la empresa biofarmac\u00e9utica MSD.<\/p>\n<p>Lara Sullivan, presidenta y CEO de Pyxis Oncology, coment\u00f3 que recibir la designaci\u00f3n de v\u00eda r\u00e1pida para PYX-201 es un hito significativo, ya que reconoce el potencial de la empresa para abordar una necesidad m\u00e9dica importante en el R\/M HNSCC. Esta designaci\u00f3n destaca la urgencia de ofrecer opciones de tratamiento diferenciadas a los pacientes y ayudar\u00e1 a acelerar el desarrollo de PYX-201 mientras reclutan pacientes para su ensayo.<\/p>\n<p>El carcinoma de c\u00e9lulas escamosas es un tipo de c\u00e1ncer de cabeza y cuello que se origina en el revestimiento mucoso de la cavidad oral. En mayo de 2023, Pyxis firm\u00f3 un acuerdo definitivo para comprar Apexigen por 16 millones de d\u00f3lares.<\/p>\n<p>\u00a1Suscr\u00edbete a nuestro resumen diario de noticias!<\/p>\n","protected":false},"excerpt":{"rendered":"<p>La terapia est\u00e1 destinada a personas cuya enfermedad ha avanzado despu\u00e9s de recibir tratamiento con quimioterapia a base de platino. Si es posible, incluya algunos nombres de medicamentos en la explicaci\u00f3n.<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","ast-disable-related-posts":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"footnotes":""},"categories":[313],"tags":[],"class_list":["post-1268","post","type-post","status-publish","format-standard","hentry","category-uncategorized-es"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.0 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>La FDA otorga el estatus de v\u00eda r\u00e1pida al PYX-201 de Pyxis. - International Online Pharmacy<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.efhss.com\/pharmacy\/es\/la-fda-otorga-el-estatus-de-via-rapida-al-pyx-201-de-pyxis\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"La FDA otorga el estatus de v\u00eda r\u00e1pida al PYX-201 de Pyxis. - International Online Pharmacy\" \/>\n<meta property=\"og:description\" content=\"La terapia est\u00e1 destinada a personas cuya enfermedad ha avanzado despu\u00e9s de recibir tratamiento con quimioterapia a base de platino. Si es posible, incluya algunos nombres de medicamentos en la explicaci\u00f3n.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.efhss.com\/pharmacy\/es\/la-fda-otorga-el-estatus-de-via-rapida-al-pyx-201-de-pyxis\/\" \/>\n<meta property=\"og:site_name\" content=\"International Online Pharmacy\" \/>\n<meta property=\"article:published_time\" content=\"2025-02-25T00:00:00+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-02-27T16:29:32+00:00\" \/>\n<meta name=\"author\" content=\"author\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"author\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"La FDA otorga el estatus de v\u00eda r\u00e1pida al PYX-201 de Pyxis. - International Online Pharmacy","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.efhss.com\/pharmacy\/es\/la-fda-otorga-el-estatus-de-via-rapida-al-pyx-201-de-pyxis\/","og_locale":"en_US","og_type":"article","og_title":"La FDA otorga el estatus de v\u00eda r\u00e1pida al PYX-201 de Pyxis. - International Online Pharmacy","og_description":"La terapia est\u00e1 destinada a personas cuya enfermedad ha avanzado despu\u00e9s de recibir tratamiento con quimioterapia a base de platino. Si es posible, incluya algunos nombres de medicamentos en la explicaci\u00f3n.","og_url":"https:\/\/www.efhss.com\/pharmacy\/es\/la-fda-otorga-el-estatus-de-via-rapida-al-pyx-201-de-pyxis\/","og_site_name":"International Online Pharmacy","article_published_time":"2025-02-25T00:00:00+00:00","article_modified_time":"2025-02-27T16:29:32+00:00","author":"author","twitter_card":"summary_large_image","twitter_misc":{"Written by":"author","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.efhss.com\/pharmacy\/es\/la-fda-otorga-el-estatus-de-via-rapida-al-pyx-201-de-pyxis\/#article","isPartOf":{"@id":"https:\/\/www.efhss.com\/pharmacy\/es\/la-fda-otorga-el-estatus-de-via-rapida-al-pyx-201-de-pyxis\/"},"author":{"name":"author","@id":"https:\/\/www.efhss.com\/pharmacy\/#\/schema\/person\/bd82616b58021f4f263c2ddb64bbd317"},"headline":"La FDA otorga el estatus de v\u00eda r\u00e1pida al PYX-201 de Pyxis.","datePublished":"2025-02-25T00:00:00+00:00","dateModified":"2025-02-27T16:29:32+00:00","mainEntityOfPage":{"@id":"https:\/\/www.efhss.com\/pharmacy\/es\/la-fda-otorga-el-estatus-de-via-rapida-al-pyx-201-de-pyxis\/"},"wordCount":310,"commentCount":0,"publisher":{"@id":"https:\/\/www.efhss.com\/pharmacy\/#organization"},"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/www.efhss.com\/pharmacy\/es\/la-fda-otorga-el-estatus-de-via-rapida-al-pyx-201-de-pyxis\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/www.efhss.com\/pharmacy\/es\/la-fda-otorga-el-estatus-de-via-rapida-al-pyx-201-de-pyxis\/","url":"https:\/\/www.efhss.com\/pharmacy\/es\/la-fda-otorga-el-estatus-de-via-rapida-al-pyx-201-de-pyxis\/","name":"La FDA otorga el estatus de v\u00eda r\u00e1pida al PYX-201 de Pyxis. - International Online Pharmacy","isPartOf":{"@id":"https:\/\/www.efhss.com\/pharmacy\/#website"},"datePublished":"2025-02-25T00:00:00+00:00","dateModified":"2025-02-27T16:29:32+00:00","breadcrumb":{"@id":"https:\/\/www.efhss.com\/pharmacy\/es\/la-fda-otorga-el-estatus-de-via-rapida-al-pyx-201-de-pyxis\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.efhss.com\/pharmacy\/es\/la-fda-otorga-el-estatus-de-via-rapida-al-pyx-201-de-pyxis\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.efhss.com\/pharmacy\/es\/la-fda-otorga-el-estatus-de-via-rapida-al-pyx-201-de-pyxis\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.efhss.com\/pharmacy\/"},{"@type":"ListItem","position":2,"name":"La FDA otorga el estatus de v\u00eda r\u00e1pida al PYX-201 de Pyxis."}]},{"@type":"WebSite","@id":"https:\/\/www.efhss.com\/pharmacy\/#website","url":"https:\/\/www.efhss.com\/pharmacy\/","name":"International Online Pharmacy","description":"","publisher":{"@id":"https:\/\/www.efhss.com\/pharmacy\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.efhss.com\/pharmacy\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.efhss.com\/pharmacy\/#organization","name":"International Online Pharmacy","url":"https:\/\/www.efhss.com\/pharmacy\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.efhss.com\/pharmacy\/#\/schema\/logo\/image\/","url":"https:\/\/www.efhss.com\/pharmacy\/wp-content\/uploads\/2024\/01\/Logo-IOP.jpg","contentUrl":"https:\/\/www.efhss.com\/pharmacy\/wp-content\/uploads\/2024\/01\/Logo-IOP.jpg","width":100,"height":100,"caption":"International Online Pharmacy"},"image":{"@id":"https:\/\/www.efhss.com\/pharmacy\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/www.efhss.com\/pharmacy\/#\/schema\/person\/bd82616b58021f4f263c2ddb64bbd317","name":"author","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.efhss.com\/pharmacy\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/f40248c4296dc36ffdef8ff0ec5081203b8cda428495941d7a5881c1f7a3e459?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/f40248c4296dc36ffdef8ff0ec5081203b8cda428495941d7a5881c1f7a3e459?s=96&d=mm&r=g","caption":"author"},"sameAs":["http:\/\/www.efhss.com"],"url":"https:\/\/www.efhss.com\/pharmacy\/author\/author\/"}]}},"lang":"es","translations":{"es":1268},"pll_sync_post":[],"_links":{"self":[{"href":"https:\/\/www.efhss.com\/pharmacy\/wp-json\/wp\/v2\/posts\/1268","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.efhss.com\/pharmacy\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.efhss.com\/pharmacy\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.efhss.com\/pharmacy\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.efhss.com\/pharmacy\/wp-json\/wp\/v2\/comments?post=1268"}],"version-history":[{"count":1,"href":"https:\/\/www.efhss.com\/pharmacy\/wp-json\/wp\/v2\/posts\/1268\/revisions"}],"predecessor-version":[{"id":1309,"href":"https:\/\/www.efhss.com\/pharmacy\/wp-json\/wp\/v2\/posts\/1268\/revisions\/1309"}],"wp:attachment":[{"href":"https:\/\/www.efhss.com\/pharmacy\/wp-json\/wp\/v2\/media?parent=1268"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.efhss.com\/pharmacy\/wp-json\/wp\/v2\/categories?post=1268"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.efhss.com\/pharmacy\/wp-json\/wp\/v2\/tags?post=1268"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}